RAPT - RAPT Therapeutics, Inc. Common Stock

Day	1m	10m	60m	PreMarket	Market	AfterHours	Gap
25.0 2.18 (8.7%)	---	---	---	-2.0 (-7.98%)	1.77 (6.95%)	0.0 (0.0%)	-1.99 (-7.95%)

RAPT Therapeutics Inc is a clinical-stage immunology-based biopharmaceutical company. It is focused on discovering, developing, and commercializing oral small-molecule therapies for patients with some unmet needs in oncology and inflammatory diseases. The company pipeline products include FLX475, designed to selectively inhibit the migration of immunosuppressive regulatory T cells into tumors; and RPT193, designed to selectively inhibit the migration of type 2 T helper cells into inflamed tissues.

Category: PHARMACEUTICAL PREPARATIONS

Market Period: Closed

Earnings & Ratios

Basic EPS:: -0.65
Diluted EPS:: -0.65
Basic P/E:: -41.8077
Diluted P/E:: -41.8077
RSI(14) 1m:: 56.07
VWAP:: 27.12
RVol:: 0.4666

Events

Period	Kind	Movement	Occurred At
1m	Price increase 1m	27.55 +0.3 (+1.12%)	Oct 15 14:45
1m	Price decrease 1m	27.25 -0.36 (-1.32%)	Oct 15 14:44
60m	Price increase 60m	27.82 +1.33 (+5.0%)	Oct 15 11:32
Day	Price increase day	27.63 +2.63 (+10.5%)	Oct 15 11:27
1m	Price increase 1m	26.0 +0.3 (+1.19%)	Oct 15 10:50